These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 31932990)
1. Preparation of Ergosterol-Loaded Nanostructured Lipid Carriers for Enhancing Oral Bioavailability and Antidiabetic Nephropathy Effects. Dong Z; Iqbal S; Zhao Z AAPS PharmSciTech; 2020 Jan; 21(2):64. PubMed ID: 31932990 [TBL] [Abstract][Full Text] [Related]
2. Formulation, Characterization, and Pharmacokinetic Studies of 6-Gingerol-Loaded Nanostructured Lipid Carriers. Wei Q; Yang Q; Wang Q; Sun C; Zhu Y; Niu Y; Yu J; Xu X AAPS PharmSciTech; 2018 Nov; 19(8):3661-3669. PubMed ID: 30324361 [TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization, and Saghafi Z; Mohammadi M; Mahboobian MM; Derakhshandeh K Drug Dev Ind Pharm; 2021 Mar; 47(3):509-520. PubMed ID: 33650445 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation. Dudhipala N; Janga KY; Gorre T Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077 [TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization and pharmacokinetic studies of linalool-loaded nanostructured lipid carriers. Shi F; Zhao Y; Firempong CK; Xu X Pharm Biol; 2016 Oct; 54(10):2320-8. PubMed ID: 26986932 [TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability. Teng Z; Yu M; Ding Y; Zhang H; Shen Y; Jiang M; Liu P; Opoku-Damoah Y; Webster TJ; Zhou J Int J Nanomedicine; 2019; 14():119-133. PubMed ID: 30613141 [TBL] [Abstract][Full Text] [Related]
7. Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo Studies. Singh A; Neupane YR; Mangla B; Kohli K J Pharm Sci; 2019 Oct; 108(10):3382-3395. PubMed ID: 31201904 [TBL] [Abstract][Full Text] [Related]
8. Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption. Zhou X; Zhang X; Ye Y; Zhang T; Wang H; Ma Z; Wu B Int J Pharm; 2015 Feb; 479(2):391-8. PubMed ID: 25556104 [TBL] [Abstract][Full Text] [Related]
9. Selenium-coated nanostructured lipid carriers used for oral delivery of berberine to accomplish a synergic hypoglycemic effect. Yin J; Hou Y; Yin Y; Song X Int J Nanomedicine; 2017; 12():8671-8680. PubMed ID: 29263662 [TBL] [Abstract][Full Text] [Related]
10. Nanostructured lipid carriers with exceptional gastrointestinal stability and inhibition of P-gp efflux for improved oral delivery of tilmicosin. Zhang Q; Yang H; Sahito B; Li X; Peng L; Gao X; Ji H; Wang L; Jiang S; Guo D Colloids Surf B Biointerfaces; 2020 Mar; 187():110649. PubMed ID: 31767412 [TBL] [Abstract][Full Text] [Related]
11. Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides. Yang G; Wu F; Chen M; Jin J; Wang R; Yuan Y Int J Nanomedicine; 2019; 14():2267-2280. PubMed ID: 31015758 [TBL] [Abstract][Full Text] [Related]
12. Ergosterol-loaded poly(lactide-co-glycolide) nanoparticles with enhanced in vitro antitumor activity and oral bioavailability. Zhang HY; Firempong CK; Wang YW; Xu WQ; Wang MM; Cao X; Zhu Y; Tong SS; Yu JN; Xu XM Acta Pharmacol Sin; 2016 Jun; 37(6):834-44. PubMed ID: 27133301 [TBL] [Abstract][Full Text] [Related]
13. Repaglinide-loaded nanostructured lipid carriers with different particle sizes for improving oral absorption: preparation, characterization, pharmacokinetics, and Wu L; Zhao L; Su X; Zhang P; Ling G Drug Deliv; 2020 Dec; 27(1):400-409. PubMed ID: 31729898 [TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid-coated cationic nanostructured lipid carriers for oral vincristine sulfate delivery. Gao X; Zhang J; Xu Q; Huang Z; Wang Y; Shen Q Drug Dev Ind Pharm; 2017 Apr; 43(4):661-667. PubMed ID: 28043185 [TBL] [Abstract][Full Text] [Related]
15. Quality by design (QbD)-based fabrication of atazanavir-loaded nanostructured lipid carriers for lymph targeting: bioavailability enhancement using chylomicron flow block model and toxicity studies. Gurumukhi VC; Bari SB Drug Deliv Transl Res; 2022 May; 12(5):1230-1252. PubMed ID: 34110597 [TBL] [Abstract][Full Text] [Related]
16. Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers. El-Helw AR; Fahmy UA Int J Nanomedicine; 2015; 10():5797-804. PubMed ID: 26396513 [TBL] [Abstract][Full Text] [Related]
17. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Das S; Ng WK; Tan RB Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358 [TBL] [Abstract][Full Text] [Related]
18. Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus. Yu Q; Hu X; Ma Y; Xie Y; Lu Y; Qi J; Xiang L; Li F; Wu W Drug Deliv; 2016 May; 23(4):1469-75. PubMed ID: 27187522 [TBL] [Abstract][Full Text] [Related]
19. Nanostructured Lipid Carriers Loaded with Baicalin: An Efficient Carrier for Enhanced Antidiabetic Effects. Shi F; Wei Z; Zhao Y; Xu X Pharmacogn Mag; 2016; 12(47):198-202. PubMed ID: 27601850 [TBL] [Abstract][Full Text] [Related]
20. Wang Y; Chenghao Z; Wu Z; Cui X; Ren J; Tang J Drug Dev Ind Pharm; 2023 Feb; 49(2):232-239. PubMed ID: 37039088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]